beta-adrenergic agonist

File:Epinephrine.svg (adrenaline)]]

Activation of β₁ receptors induces positive inotropic, chronotropic output of the cardiac muscle, leading to increased heart rate and blood pressure, secretion of ghrelin from the stomach, and renin release from the kidneys.{{cite journal | vauthors = Yoo B, Lemaire A, Mangmool S, Wolf MJ, Curcio A, Mao L, Rockman HA | title = Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction | journal = American Journal of Physiology. Heart and Circulatory Physiology | volume = 297 | issue = 4 | pages = H1377-H1386 | date = October 2009 | pmid = 19633206 }}

Activation of β₂ receptors induces smooth muscle relaxation in the lungs, gastrointestinal tract, uterus, and various blood vessels. Increased heart rate and heart muscle contraction are associated with the β1 receptors; however, β₂ cause vasodilation in the myocardium.{{cn|date=February 2022}}

β3 receptors are mainly located in adipose tissue.{{cite journal | vauthors = Johnson M | title = Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation | journal = The Journal of Allergy and Clinical Immunology | volume = 117 | issue = 1 | pages = 18–24; quiz 25 | date = January 2006 | pmid = 16387578 }} Activation of the β₃ receptors induces the metabolism of lipids.{{cite journal | vauthors = Lowell BB, Flier JS | title = Brown adipose tissue, beta 3-adrenergic receptors, and obesity | journal = Annual Review of Medicine | volume = 48 | pages = 307–316 | year = 1997 | pmid = 9046964 }}

Indications of administration for β agonists include:

• Bradycardia (slow heart rate)
• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Heart failure
• Allergic reactions
• Hyperkalemia
• Beta blocker poisoning
• Premature labor (this is an off-label use and could be detrimental){{Cite journal|url=https://www.fda.gov/Drugs/DrugSafety/ucm243539.htm|title = FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor|journal = FDA|date = 18 June 2019}}

Although minor compared to those of epinephrine, beta agonists usually have mild to moderate adverse effects, which include anxiety, hypertension, increased heart rate, and insomnia. Other side effects include headaches and essential tremor. Hypoglycemia was also reported due to increased secretion of insulin in the body from activation of β₂ receptors.{{cn|date=February 2022}}

In 2013, zilpaterol, a β agonist sold by Merck, was temporarily withdrawn due to signs of sickness in some cattle that were fed the drug.{{cite web|url=https://news.yahoo.com/exclusive-fda-says-working-merck-usda-cattle-drug-160545615.html |title=Exclusive: FDA says working with Merck, USDA on cattle drug Zilmax - Yahoo! News |access-date=2013-08-16 |url-status=dead |archive-url=https://web.archive.org/web/20130827081850/http://news.yahoo.com/exclusive-fda-says-working-merck-usda-cattle-drug-160545615.html |archive-date=2013-08-27 }}

Most agonists of the beta receptors are selective for one or more beta-adrenoreceptors. For example, patients with low heart rate are given beta agonist treatments that are more "cardio-selective" such as dobutamine, which increases the force of contraction of the heart muscle. Patients who are suffering from chronic inflammatory lung diseases such as asthma or COPD may be treated with medication targeted to induce more smooth muscle relaxation in the lungs and less contraction of the heart, including first-generation drugs like salbutamol (albuterol) and later-generation medications in the same class.{{cite web | vauthors = Pias MT |url=http://www.uky.edu/~mtp/OBI836AR.html | archive-url = https://web.archive.org/web/20160312082554/http://www.uky.edu/~mtp/OBI836AR.html | archive-date = 12 March 2016 |title=The Pharmacology of Adrenergic Receptors}}

β₃ agonists are currently under clinical research and are thought to increase the breakdown of lipids in obese patients.{{cite journal | vauthors = Meyers DS, Skwish S, Dickinson KE, Kienzle B, Arbeeny CM | title = Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 82 | issue = 2 | pages = 395–401 | date = February 1997 | pmid = 9024225 }}

{{Main|Beta-1_adrenergic_receptor#Agonists}}

β₁ agonists stimulate adenylyl cyclase activity and opening of calcium channel (cardiac stimulants; used to treat cardiogenic shock, acute heart failure, bradyarrhythmias). Selected examples are:

• Denopamine
• Dobutamine
• Dopexamine (β₁ and β₂)
• Epinephrine (non-selective)
• Isoprenaline (INN), isoproterenol (USAN) (β₁ and β₂)
• Prenalterol
• Xamoterol

{{Main|Beta2-adrenergic agonist|l1=Beta₂-adrenergic agonist}}

β₂ agonists stimulate adenylyl cyclase activity and closing of calcium channel (smooth muscle relaxants; used to treat asthma and COPD). Selected examples are:

{{div col|colwidth=30em}}

• Arformoterol
• Buphenine
• Clenbuterol
• Dopexamine (β₁ and β₂)
• Epinephrine (non-selective)
• Fenoterol
• Formoterol
• Isoetarine
• Isoprenaline (INN), isoproterenol (USAN) (β₁ and β₂)
• Levosalbutamol (INN), levalbuterol (USAN)
• Orciprenaline (INN), metaproterenol (USAN)
• Pirbuterol
• Procaterol
• Ritodrine
• Salbutamol (INN), albuterol (USAN)
• Salmeterol
• Terbutaline

{{div col end}}

{{main|Beta3-adrenergic agonist}}

These agents are also listed as agonists by MeSH.{{MeshPharmaList|82000318}}

{{div col|colwidth=30em}}

• Arbutamine
• Befunolol
• Bromoacetylalprenololmenthane
• Broxaterol
• Cimaterol
• Cirazoline
• Etilefrine
• Hexoprenaline
• Higenamine
• Isoxsuprine
• Mabuterol
• Methoxyphenamine
• Oxyfedrine
• Ractopamine
• Reproterol
• Rimiterol
• Tretoquinol
• Tulobuterol
• Zilpaterol
• Zinterol

{{div col end}}

• Alpha-adrenergic agonist
• Use of beta-adrenergic agonists in livestock

{{Reflist}}

• {{Commonscatinline|Beta agonists}}

{{Adrenergic agonists}}

{{Receptor agonists and antagonists}}